| Literature DB >> 27374787 |
Kenya Sato1, Ryo Oiwa1, Wakako Kumita1, Rachel Henry2, Tetsushi Sakuma3, Ryoji Ito1, Ryoko Nozu1, Takashi Inoue1, Ikumi Katano1, Kengo Sato4, Norio Okahara1, Junko Okahara1, Yoshihisa Shimizu1, Masafumi Yamamoto1, Kisaburo Hanazawa5, Takao Kawakami6, Yoshie Kametani7, Ryuji Suzuki8, Takeshi Takahashi1, Edward J Weinstein2, Takashi Yamamoto3, Yasubumi Sakakibara4, Sonoko Habu9, Jun-Ichi Hata1, Hideyuki Okano10, Erika Sasaki11.
Abstract
Recent advances in genome editing have facilitated the generation of nonhuman primate (NHP) models, with potential to unmask the complex biology of human disease not revealed by rodent models. However, their broader use is hindered by the challenges associated with generation of adult NHP models as well as the cost of their production. Here, we describe the generation of a marmoset model of severe combined immunodeficiency (SCID). This study optimized zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) to target interleukin-2 receptor subunit gamma (IL2RG) in pronuclear stage marmoset embryos. Nine of 21 neonates exhibited mutations in the IL2RG gene, concomitant with immunodeficiency, and three neonates have currently survived from 240 days to 1.8 years. Our approach demonstrates highly efficient production of founder NHP with SCID phenotypes, with promises of multiple pre-clinical and translational applications.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27374787 DOI: 10.1016/j.stem.2016.06.003
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633